Stereoselective Route to Steroid-C20 (S) or -C20 (R)
A R T I C L E S
Scheme 1. Exocyclic Stereocenters via Asymmetric
Hydrovinylation
solution to this exocylic stereochemistry problem (Scheme 1).
Both achiral and chiral ligands (Figure 2) carrying suitable
hemilabile groups such as o-benzyloxyphenyldiphenylphosphine
(L3), phospholanes (e.g., L4), and phosphoramidites (e.g., L5)
gave nearly quantitative yields of the hydrovinylation products,
which could be subjected to further functionalization via
diastereoselective reactions.
While attempting to apply the diene hydrovinylation for the
functionalization of a steroid D-ring (eq 1), it was observed,
that several excellent ligands we had initially employed either
did not react (Figure 2: Ph3P, L1, L2) or gave mixtures (L3,
L4) of stereo- and regioisomers. We anticipate this lack of
selectivity to be a recurring problem in the context of this and
other future synthetic objectives in which hydrovinylations of
key chiral intermediates will be involved. It is entirely conceiv-
able that the inherent diastereoselectivity in such intermediates
could be low or even opposite to what would be desired. Thus,
from a synthetic perspective, either enhancing the inherent
selectivity or overriding such an outcome with the use of a
tunable asymmetric catalyst will be a highly desirable goal.
Looking for a general solution to this problem, we decided to
examine the effect of ligands on the selectivity of the hydro-
vinylation reactions of 1,3-dienes 3 and 4, derived from two
prototypical steroids, estrone and 3-epiandrosterone. In this
paper, we report the results of these studies, which demonstrate
that in these steroids it is possible to install, with complete
stereoselectiVity, either C20 (R) or C20 (S) configuration by proper
choice of ligands and reaction conditions. A limited study of
the Ru-catalyzed hydrovinylation of 3 published earlier12 did
not address the key issue of control of stereoselectivity at this
stereogenic center.
conditions14 using either [(allyl)NiBr]2/Ph3P/AgOTf or [(al-
lyl)NiBr]2/(L)/(NaBARF) [L ) L1, L2; BARF ) tetrakis-(3,5-
bis-trifluoromethylphenyl)borate] at temperatures between -55
and 25 °C under 1 atm of ethylene gave no products. This lack
of reactivity is quite surprising in this otherwise broadly
applicable hydrovinylation protocol. Upon further examination
of the reaction using other ligands L3-L12, most notably the
phosphoramidites,15 under a variety of conditions, it was found
that synthetically useful levels of selectivity could be achieved
(eqs 1–3). The results are listed in Table 1.
Hydrovinylation using an achiral ligand L3 (o-benzyloxy-
phenyldiphenylphosphine) gives a mixture of C20 (S) [5] and
C20 (R) [7] epimers in a ratio of 1.0:2.5 (entry 1) along with
1,4-adducts 6 and 8 (see the following paragraphs and Sup-
porting Information for details of structural assignments).16 This
inherent selectivity for the formation of the C20 (R) adduct can
be reversed, albeit modestly, with the use of a chiral ligand,
the phospholane L4, which yields a ratio of 3:1 for 5:7 (entry
2). In addition to the formation of the byproducts, 6 and 8 (the
1,4-adducts), these reactions are also complicated by minor
isomerization of the primary products giving what appears to
be conjugated dienes. The first indication that this unwanted
isomerization can be completely blocked and exclusive selectiv-
ity for the 20(S) compound can be achieved came from ligands
L5 (RaScSc) and L10 (ScSc), which gave a clean mixture of 5
and 6, with no trace of the 20(R)-epimer 7, the 1,4-adduct 8, or
isomerization products (eq 2, entries 3 and 5-8). Typically,
the reaction is done as follows:15h a solution of 0.0025 mmol
of [(allyl)2NiBr]2 in 0.5 mL of solvent (usually CH2Cl2) and a
solution of the ligand in 0.5 mL solvent are mixed in a drybox.
This solution is added to a suspension of NaBARF (1 equiv
Results and Discussion
Our initial studies were conducted with the diene 3, readily
prepared from estrone as described previously.13 Nickel-
catalyzed hydrovinylation of 3 under our initially reported
(9) (a) Honzawa, S.; Suhara, Y.; Nihei, K.; Saito, N.; Kishimoto, S.;
Fujishima, T.; Kurihara, M.; Sugiura, T.; Waku, K.; Takayamaa, H.;
Kittaka, A. Bioorg. Med. Chem. Lett. 2003, 13, 3503, and references
cited therein. One modified D-ring analog with C20 (S)- configuration
(e.g., Ro 26-9228) was reported to increase bone mineral density
while showing reduced calciuria and calcemia compared to a C20 (R)
analog. Related compounds were found to stimulate HL-60 cell
differentiation, and hence could find application for treatment of
leukemia. For leading references, see: (b) Kabat, M. M.; Garofalo,
L. M.; Daniewski, A. J.; Hutchings, S. D.; Liu, W.; Okabe, M.;
Radinov, R.; Zhou, Y. J. Org. Chem. 2001, 66, 6141.
(14) (a) Nomura, N.; Jin, J.; Park, H.; RajanBabu, T. V. J. Am. Chem. Soc.
1998, 120, 459. (b) RajanBabu, T. V.; Nomura, N.; Jin, J.; Nandi,
M.; Park, H.; Sun, X. J. Org. Chem. 2003, 68, 8431.
(15) (a) Feringa, B. L. Acc. Chem. Res. 2000, 33, 346. (b) Arnold, L. A.;
Imbos, R.; Mandoli, A.; de Vries, A. H. M.; Naasz, R.; Feringa, B. L.
Tetrahedron 2000, 56, 2865. (c) Alexakis, A.; Rosset, S.; Allamand,
J.; March, S.; Guillen, F.; Benhaim, C. Synlett 2001, 1375. Hydro-
vinylations using phosphoramidite ligands. (d) Francio´, G.; Faraone,
F.; Leitner, W. J. Am. Chem. Soc. 2002, 124, 736. (e) Park, H.;
Kumareswaran, R.; RajanBabu, T. V. Tetrahedron 2005, 61, 6352.
(f) Smith, C. R.; RajanBabu, T. V. Org. Lett. 2008, 10, 1657. (g) For
a scalable procedure for the synthesis of phosphoramidites, see: Smith,
C. R.; Mans, D.; RajanBabu, T. V. Org. Synth. 2008, in press. (h)
Smith, C. R.; Zhang, A.; Mans, D.; RajanBabu, T. V. Org. Synth.
2008, in press.
(10) (a) Fujishima, T.; Konno, K.; Nakagawa, K.; Kurobe, M.; Okano, T.;
Takayama, H. Bioorg. Med. Chem. 2000, 8, 123. (b) Ferna´ndez, B.;
Pe´rez, J. A. M.; Granja, J. R.; Castedo, l.; Mourino, A. J. Org. Chem.
1992, 57, 3173. See also: (c) Ferna´ndez, C.; Go´mez, G.; Lago, C.;
Moma´n, E.; Fall, Y. Synlett 2005, 2163. (d) See also ref 5.
(11) (a) Zhang, A.; RajanBabu, T. V. J. Am. Chem. Soc. 2006, 128, 54.
For a recent review of hydrovinylation, see: (b) RajanBabu, T. V.
Chem. ReV. 2003, 103, 2845.
(12) He, Z.; Yi, C. S.; Donaldson, W. A. Org. Lett. 2003, 5, 1567.
(13) De Riccardis, F.; Meo, D.; Izzo, I.; Di Filoppo, M.; Casapullo, A.
Eur. J. Org. Chem. 1998, 1965.
(16) See Supporting Information for 1H and 13C NMR spectra.
9
J. AM. CHEM. SOC. VOL. 130, NO. 28, 2008 9001